Preventing Blood Clots in Hospitalized Patients
Author Information
Author(s): Samama Meyer Michel, Kleber Franz-Xaver
Primary Institution: Département d'Hématologie Biologique, Hôtel Dieu, Paris, France
Hypothesis
What are the best methods for preventing venous thromboembolism (VTE) in hospitalized medical patients?
Conclusion
Thromboprophylaxis with low-molecular-weight heparin (LMWH) is as effective as unfractionated heparin (UFH) for preventing VTE in at-risk medical patients, but has a better safety profile.
Supporting Evidence
- Thromboprophylaxis with LMWH reduces the risk of VTE by 45–66%.
- LMWH has a better safety profile than UFH.
- UFH t.i.d. is recommended for use as thromboprophylaxis in hospitalized medical patients.
Takeaway
Doctors can help prevent blood clots in sick patients by giving them special medicine. Some medicines are better and safer than others.
Methodology
Review of recent advances in thromboprophylaxis and analysis of randomized clinical studies.
Potential Biases
Potential bias in the selection of studies and the interpretation of results.
Limitations
The review does not specify dosing regimens for UFH and lacks data on the long-term effects of thromboprophylaxis.
Participant Demographics
Hospitalized acutely ill medical patients, including those with congestive heart failure and severe respiratory disease.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 0.22–0.63
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website